[1]
H. Naser and N. Hadi, “Association of SGLT2 Inhibitor Use with Circulating Pyroptosis-Related Biomarkers in Iraqi Patients with Diabetic Kidney Disease: A Cross-Sectional Study”, J. Contemp. Med. Sci., vol. 12, no. 4, Aug. 2026.